To evaluate the effectiveness and safety of different pharmacological interventions to treat chemotherapy induced diarrhoea in patients with colorectal cancer.
This is a protocol.
Interventions for reducing diarrhoea in patients receiving chemotherapy for colorectal cancer
You may also be interested in:
- Chemotherapy improves the survival of people with advanced colorectal cancer, but the adverse effects and impact on quality of life are not yet known.
- Duration of 5FU based chemotherapy in adjuvant setting for colorectal cancer should not exceed 6 months.
- Hepatic arterial infusion versus systemic chemotherapy for colorectal cancer liver metastasis
- Chemotherapy delivered via the hepatic artery following surgical resection of liver metastases arising from colorectal cancer does not improve survival.
- Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progression-free survival in patients with advanced and/or metastatic colorectal cancer